Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Account Payables (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Change in Account Payables for 4 consecutive years, with $209.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 64.57% year-over-year to $209.0 million, compared with a TTM value of $90.0 million through Dec 2025, up 50.0%, and an annual FY2025 reading of $90.0 million, up 50.0% over the prior year.
  • Change in Account Payables was $209.0 million for Q4 2025 at GE HealthCare Technologies, up from -$6.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $266.0 million in Q2 2022 and bottomed at -$402.0 million in Q4 2022.
  • Average Change in Account Payables over 4 years is $1.1 million, with a median of $23.0 million recorded in 2022.
  • The sharpest move saw Change in Account Payables crashed 194.25% in 2023, then soared 1914.29% in 2024.
  • Year by year, Change in Account Payables stood at -$402.0 million in 2022, then skyrocketed by 98.26% to -$7.0 million in 2023, then skyrocketed by 1914.29% to $127.0 million in 2024, then surged by 64.57% to $209.0 million in 2025.
  • Business Quant data shows Change in Account Payables for GEHC at $209.0 million in Q4 2025, -$6.0 million in Q3 2025, and -$259.0 million in Q2 2025.